Latest Articles

Publication Date
All News Scientific
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials - The Lancet

Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials The Lancet

Published: April 30, 2024, 7 a.m.
Read Full Article
Combining the prognostic role of age with molecular advances in the understanding of endometrial cancer - The Lancet

Combining the prognostic role of age with molecular advances in the understanding of endometrial cancer The Lancet

Published: April 30, 2024, 7 a.m.
Read Full Article
Early GnRH-agonist therapy does not negatively impact the endometrial repair process or live birth rate - Frontiers

Early GnRH-agonist therapy does not negatively impact the endometrial repair process or live birth rate Frontiers

Published: April 29, 2024, 7 a.m.
Read Full Article
Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer - OncLive

Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer OncLive

Published: April 24, 2024, 7 a.m.
Read Full Article
GSK's endometrial cancer drug receives FDA approval - ShareCast

GSK's endometrial cancer drug receives FDA approval ShareCast

Published: April 24, 2024, 7 a.m.
Read Full Article
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - PR Newswire

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting PR Newswire

Published: April 24, 2024, 7 a.m.
Read Full Article
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - Investor Relations | Karyopharm Therapeutics

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting Investor Relations | Karyopharm Therapeutics

Published: April 24, 2024, 7 a.m.
Read Full Article
An endometrial biomimetic extracellular matrix (ECM) for enhanced endometrial regeneration using hyaluronic acid hydrogel containing recombinant human type III collagen - ScienceDirect.com

An endometrial biomimetic extracellular matrix (ECM) for enhanced endometrial regeneration using hyaluronic acid hydrogel containing recombinant human type III collagen ScienceDirect.com

Published: April 21, 2024, 4:30 p.m.
Read Full Article
Umbilical cord mesenchymal stem cell-derived exosomes inhibits fibrosis in human endometrial stromal cells via miR-140-3p/FOXP1/Smad axis - Nature.com

Umbilical cord mesenchymal stem cell-derived exosomes inhibits fibrosis in human endometrial stromal cells via miR-140-3p/FOXP1/Smad axis Nature.com

Published: April 9, 2024, 7 a.m.
Read Full Article
Novel ADC and Immunotherapy Combo Shows Promise for Endometrial Cancer - Cancer Health Treatment News

Novel ADC and Immunotherapy Combo Shows Promise for Endometrial Cancer Cancer Health Treatment News

Published: April 9, 2024, 7 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!